273 related articles for article (PubMed ID: 16967049)
21. Proteinase-activated receptor 2 mediates thermal hyperalgesia and is upregulated in a rat model of chronic pancreatitis.
Zhang W; Gao J; Zhao T; Wei L; Wu W; Bai Y; Zou D; Li Z
Pancreas; 2011 Mar; 40(2):300-7. PubMed ID: 21311307
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4.
Zhao P; Lieu T; Barlow N; Metcalf M; Veldhuis NA; Jensen DD; Kocan M; Sostegni S; Haerteis S; Baraznenok V; Henderson I; Lindström E; Guerrero-Alba R; Valdez-Morales EE; Liedtke W; McIntyre P; Vanner SJ; Korbmacher C; Bunnett NW
J Biol Chem; 2014 Sep; 289(39):27215-27234. PubMed ID: 25118282
[TBL] [Abstract][Full Text] [Related]
23. The C-terminus of murine S100A9 inhibits hyperalgesia and edema induced by jararhagin.
Dale CS; Gonçalves LR; Juliano L; Juliano MA; da Silva AM; Giorgi R
Peptides; 2004 Jan; 25(1):81-9. PubMed ID: 15003359
[TBL] [Abstract][Full Text] [Related]
24. Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception.
Wu J; Liu TT; Zhou YM; Qiu CY; Ren P; Jiao M; Hu WP
J Neuroinflammation; 2017 Jul; 14(1):150. PubMed ID: 28754162
[TBL] [Abstract][Full Text] [Related]
25. Heat hyperalgesia induced by endoneurial nerve growth factor and the expression of substance P in primary sensory neurons.
Ruiz G; Baños JE
Int J Neurosci; 2009; 119(2):185-203. PubMed ID: 19125373
[TBL] [Abstract][Full Text] [Related]
26. Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2.
Kawao N; Ikeda H; Kitano T; Kuroda R; Sekiguchi F; Kataoka K; Kamanaka Y; Kawabata A
J Pharmacol Sci; 2004 Mar; 94(3):277-85. PubMed ID: 15037813
[TBL] [Abstract][Full Text] [Related]
27. Chronic compression or acute dissociation of dorsal root ganglion induces cAMP-dependent neuronal hyperexcitability through activation of PAR2.
Huang ZJ; Li HC; Cowan AA; Liu S; Zhang YK; Song XJ
Pain; 2012 Jul; 153(7):1426-1437. PubMed ID: 22541444
[TBL] [Abstract][Full Text] [Related]
28. Protein Kinase D and Gβγ Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane.
Jensen DD; Zhao P; Jimenez-Vargas NN; Lieu T; Gerges M; Yeatman HR; Canals M; Vanner SJ; Poole DP; Bunnett NW
J Biol Chem; 2016 May; 291(21):11285-99. PubMed ID: 27030010
[TBL] [Abstract][Full Text] [Related]
29. Peripheral PAR-2 triggers thermal hyperalgesia and nociceptive responses in rats.
Kawabata A; Kawao N; Kuroda R; Tanaka A; Itoh H; Nishikawa H
Neuroreport; 2001 Mar; 12(4):715-9. PubMed ID: 11277570
[TBL] [Abstract][Full Text] [Related]
30. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain.
Dai Y; Moriyama T; Higashi T; Togashi K; Kobayashi K; Yamanaka H; Tominaga M; Noguchi K
J Neurosci; 2004 May; 24(18):4293-9. PubMed ID: 15128843
[TBL] [Abstract][Full Text] [Related]
31. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport.
Vergnolle N; Macnaughton WK; Al-Ani B; Saifeddine M; Wallace JL; Hollenberg MD
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7766-71. PubMed ID: 9636225
[TBL] [Abstract][Full Text] [Related]
32. Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation.
Al-Ani B; Saifeddine M; Kawabata A; Hollenberg MD
Br J Pharmacol; 1999 Nov; 128(5):1105-13. PubMed ID: 10556949
[TBL] [Abstract][Full Text] [Related]
33. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.
Tu NH; Jensen DD; Anderson BM; Chen E; Jimenez-Vargas NN; Scheff NN; Inoue K; Tran HD; Dolan JC; Meek TA; Hollenberg MD; Liu CZ; Vanner SJ; Janal MN; Bunnett NW; Edgington-Mitchell LE; Schmidt BL
J Neurosci; 2021 Jan; 41(1):193-210. PubMed ID: 33172978
[TBL] [Abstract][Full Text] [Related]
34. Involvement of protease-activated receptor 2 in nociceptive behavior in a rat model of bone cancer.
Bao Y; Hua B; Hou W; Shi Z; Li W; Li C; Chen C; Liu R; Qin Y
J Mol Neurosci; 2014 Apr; 52(4):566-76. PubMed ID: 24057889
[TBL] [Abstract][Full Text] [Related]
35. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor.
Patwardhan AM; Diogenes A; Berg KA; Fehrenbacher JC; Clarke WP; Akopian AN; Hargreaves KM
Pain; 2006 Nov; 125(1-2):114-24. PubMed ID: 16781076
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of protease-activated receptor 2 and 4 within dorsal root ganglia in a rat model of bone cancer pain.
Bao Y; Hou W; Yang L; Liu R; Gao Y; Kong X; Shi Z; Li W; Zheng H; Jiang S; Hua B
J Mol Neurosci; 2015 Mar; 55(3):706-14. PubMed ID: 25344153
[TBL] [Abstract][Full Text] [Related]
37. Capsazepine inhibits thermal hyperalgesia but not nociception triggered by protease-activated receptor-2 in rats.
Kawao N; Shimada C; Itoh H; Kuroda R; Kawabata A
Jpn J Pharmacol; 2002 Jun; 89(2):184-7. PubMed ID: 12120762
[TBL] [Abstract][Full Text] [Related]
38. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).
Suen JY; Barry GD; Lohman RJ; Halili MA; Cotterell AJ; Le GT; Fairlie DP
Br J Pharmacol; 2012 Mar; 165(5):1413-23. PubMed ID: 21806599
[TBL] [Abstract][Full Text] [Related]
39. The role of protease-activated receptor-2 (PAR2) in the modulation of beating of the mouse isolated ureter: lack of involvement of mast cells or sensory nerves.
Moffatt JD; Cocks TM
Br J Pharmacol; 1999 Oct; 128(4):860-4. PubMed ID: 10556919
[TBL] [Abstract][Full Text] [Related]
40. Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine tolerance.
Bao Y; Gao Y; Hou W; Yang L; Kong X; Zheng H; Li C; Hua B
Int J Cancer; 2015 Sep; 137(6):1475-83. PubMed ID: 25708385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
